These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 2453498)
1. Separation of the tumor rejection antigen of Rous sarcoma virus-induced murine fibrosarcoma. Suda T; Shimizu J; Mizushima Y; Fujiwara H; Hamaoka T Jpn J Cancer Res; 1988 Mar; 79(3):365-74. PubMed ID: 2453498 [TBL] [Abstract][Full Text] [Related]
2. The tumor rejection antigen separated from Rous sarcoma virus-induced murine fibrosarcoma exhibits a molecular weight of approximately 60 kD but differs from functional pp60src. Suda T; Shimizu J; Muramatsu M; Kimura K; Yoshida TO; Fukami Y; Fujiwara H; Hamaoka T Jpn J Cancer Res; 1989 Sep; 80(9):879-86. PubMed ID: 2480944 [TBL] [Abstract][Full Text] [Related]
3. [Biochemical characterization of tumor rejection antigen (TRA) and genetic control in anti-TRA immune responses]. Fujiwara H; Suda T; Shimizu J; Muramatsu M; Kimura K; Hamaoka T Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):646-52. PubMed ID: 2468311 [TBL] [Abstract][Full Text] [Related]
4. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. Shimizu J; Suda T; Yoshioka T; Kosugi A; Fujiwara H; Hamaoka T J Immunol; 1989 Feb; 142(3):1053-9. PubMed ID: 2464022 [TBL] [Abstract][Full Text] [Related]
5. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. Hamaoka T; Shimizu J; Suda T; Fujiwara H Princess Takamatsu Symp; 1988; 19():265-75. PubMed ID: 3269360 [TBL] [Abstract][Full Text] [Related]
6. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850 [TBL] [Abstract][Full Text] [Related]
7. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Srivastava PK; DeLeo AB; Old LJ Proc Natl Acad Sci U S A; 1986 May; 83(10):3407-11. PubMed ID: 3458189 [TBL] [Abstract][Full Text] [Related]
8. No expression of a Rous sarcoma virus-induced tumor antigen in mammalian cells infected with retroviruses transducing other oncogenes of the src gene family. Kuzumaki N; Yamagiwa S; Oikawa T J Natl Cancer Inst; 1985 Apr; 74(4):889-92. PubMed ID: 2985859 [TBL] [Abstract][Full Text] [Related]
9. Correlation between tumor-specific surface antigens and src gene expression in Rous sarcoma virus-induced rat tumors. Kuzumaki N; Minakawa H; Matsuo T; Haraguchi S; Yoshida TO Eur J Cancer Clin Oncol; 1983 Mar; 19(3):401-9. PubMed ID: 6305667 [TBL] [Abstract][Full Text] [Related]
10. Biologic and biochemical properties of detergent-solubilized tumor-specific transplantation antigen from a simian virus 40-induced neoplasm: brief communication. Natori T; Law LW; Appella E J Natl Cancer Inst; 1977 Oct; 59(4):1331-3. PubMed ID: 198560 [TBL] [Abstract][Full Text] [Related]
11. Solubilization and partial characterization of a tumor-rejection antigen from an ultraviolet light-induced murine tumor. Ransom JH; Schengrund CL; Bartlett GL Int J Cancer; 1981; 27(4):545-54. PubMed ID: 7275357 [TBL] [Abstract][Full Text] [Related]
12. Individually distinct tumor-specific cell surface antigen identified by monoclonal antibody on a Rous sarcoma virus-induced mouse tumor. Kuzumaki N; Minakawa H; Miyazaki T; Haraguchi S; Matsuo T; Yoshida TO J Natl Cancer Inst; 1982 Aug; 69(2):527-30. PubMed ID: 6287079 [TBL] [Abstract][Full Text] [Related]
13. Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40. Drapkin MS; Appella E; Law LW J Natl Cancer Inst; 1974 Jan; 52(1):259-64. PubMed ID: 4129833 [No Abstract] [Full Text] [Related]
14. Investigations on the aminoacid content of tumor associated antigens of rat sarcoma cells induced by virus. Alexandrov I; Wesselinova D; Alexandrova R Cancer Biochem Biophys; 1999 Jul; 17(1-2):147-54. PubMed ID: 10738910 [TBL] [Abstract][Full Text] [Related]
15. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma. Natori T; Law LW; Appella E Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494 [TBL] [Abstract][Full Text] [Related]
16. Immunization with a lipid-conjugated membrane antigen to suppress growth of a fibrosarcoma induced by simian virus 40. Hunter RL; Strickland F J Natl Cancer Inst; 1975 May; 54(5):1157-63. PubMed ID: 165307 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a soluble partially purified oncofetal antigen from murine fibrosarcoma in syngeneic mice. Barsoum AL; Coggin JH J Biol Response Mod; 1989 Dec; 8(6):579-92. PubMed ID: 2600602 [TBL] [Abstract][Full Text] [Related]
18. Independent expression of common and private tumor-specific cell surface antigens in somatic cell hybrids between Rous sarcoma virus-transformed and normal cells. Kuzumaki N; Oikawa T; Yamada T J Natl Cancer Inst; 1984 Feb; 72(2):387-93. PubMed ID: 6319792 [TBL] [Abstract][Full Text] [Related]
19. Tumor-specific T cell lines: capacity to proliferate and produce interleukin 2 in response to various forms of tumor antigens. Shimizu J; Suda T; Katagiri T; Fujiwara H; Hamaoka T Jpn J Cancer Res; 1992 Feb; 83(2):184-93. PubMed ID: 1372887 [TBL] [Abstract][Full Text] [Related]
20. src-specific immune regression of Rous sarcoma virus-induced tumors. Gelman IH; Hanafusa H Cancer Res; 1993 Feb; 53(4):915-20. PubMed ID: 8381333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]